| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.037 | 0.8 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |